General Information
Version
24/04/2024
Revision date
2024-04-24
Product name
Sodium dodecyl sulphate
CAS No.
151-21-3
1.2.1 Relevant identified uses
Laboratory use
Icons in SDS
Company Information
company name
Frederiksen Scientific A/S
e-mail address of the competent person responsible for the Safety Data Sheet
aca@frederiksen-scientific.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H228, H302, H315, H318, H412
Hazard statements
Code
Statements
H228
Flammable solid
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flam. Sol. 2; H228, Flammable solid. Acute Tox. 4; H302, Harmful if swallowed. Skin Irrit. 2; H315, Causes skin irritation. Eye Dam. 1; H318, Causes serious eye damage. Aquatic Chronic 3; H412, Harmful to aquatic life with long lasting effects.
Signal word
Danger
Hazard statements
Flammable solid. (H228) Harmful if swallowed. (H302) Causes skin irritation. (H315) Causes serious eye damage. (H318) Harmful to aquatic life with long lasting effects. (H412)
Precautionary statements
-
Prevention
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. (P210) Wash hands and exposed skin thoroughly after handling. (P264) Wear eye protection/protective clothing. (P280) Avoid release to the environment. (P273)
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. (P305+P351+P338) Immediately call a POISON CENTER/doctor. (P310) In case of fire: Use water mist/carbon dioxide/alcohol-resistant foam to extinguish. (P370+P378)
Storage
-
Disposal
Dispose of contents/container in accordance with local regulation (P501)
Hazardous Ingredients
sodium dodecyl sulphate
2.3 Other hazards
Additional warnings Dust from flammable solids can be explosive, even if they are not hazardous substances. This mixture/product does not contain any substances known to fulfil the criteria for PBT This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
